Combination products represent an important and growing category of therapeutic and diagnostic products under the U.S. Food and Drug Administration’s (FDA) regulatory authority.

In part one yesterday, we looked at stats of the Boston Red Sox bullpen, a typical example of baseball’s tendency to find special cause in just about anything.